Empower Clinics Inc. (EPWCF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 9.18 Million USD | -19.64% |
| 2021 | 11.43 Million USD | -22.35% |
| 2020 | 14.72 Million USD | 190.31% |
| 2019 | 5.07 Million USD | 44.46% |
| 2018 | 3.51 Million USD | 828.57% |
| 2017 | 378 Thousand USD | 10.85% |
| 2016 | 341 Thousand USD | 43.88% |
| 2015 | 237 Thousand USD | 6.28% |
| 2014 | 223 Thousand USD | -94.14% |
| 2013 | 3.8 Million USD | -63.18% |
| 2012 | 10.33 Million USD | 626.95% |
| 2011 | 1.42 Million USD | 149.78% |
| 2010 | 568.91 Thousand USD | 348.04% |
| 2009 | 126.97 Thousand USD | 202.34% |
| 2008 | 41.99 Thousand USD | 292.87% |
| 2007 | 10.69 Thousand USD | -30.4% |
| 2006 | 15.36 Thousand USD | 173.21% |
| 2005 | 5622.00 USD | -8.41% |
| 2004 | 6138.00 USD | -11.65% |
| 2003 | 6947.00 USD | -64.52% |
| 2002 | 19.58 Thousand USD | 12.42% |
| 2001 | 17.41 Thousand USD | -54.66% |
| 2000 | 38.41 Thousand USD | 532.67% |
| 1999 | 6072.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q1 | 13.41 Million USD | 17.34% |
| 2022 Q2 | 9.29 Million USD | -30.67% |
| 2022 Q4 | 9.18 Million USD | 4.31% |
| 2022 FY | 9.18 Million USD | -19.67% |
| 2022 Q3 | 8.8 Million USD | -5.34% |
| 2021 Q1 | 12.55 Million USD | -14.72% |
| 2021 FY | 11.43 Million USD | -22.35% |
| 2021 Q2 | 12.11 Million USD | -3.5% |
| 2021 Q3 | 9.2 Million USD | -24.0% |
| 2021 Q4 | 11.43 Million USD | 24.14% |
| 2020 Q1 | 5.08 Million USD | 0.31% |
| 2020 Q3 | 4.62 Million USD | -7.27% |
| 2020 Q2 | 4.99 Million USD | -1.86% |
| 2020 Q4 | 14.72 Million USD | 217.98% |
| 2020 FY | 14.72 Million USD | 190.31% |
| 2019 FY | 5.07 Million USD | 44.46% |
| 2019 Q4 | 5.07 Million USD | 7.22% |
| 2019 Q1 | 5.46 Million USD | 55.69% |
| 2019 Q2 | 5.4 Million USD | -1.17% |
| 2019 Q3 | 4.72 Million USD | -12.44% |
| 2018 Q2 | 3.67 Million USD | 870.31% |
| 2018 Q3 | 4.37 Million USD | 18.86% |
| 2018 Q4 | 3.51 Million USD | -19.7% |
| 2018 FY | 3.51 Million USD | 828.57% |
| 2018 Q1 | 379 Thousand USD | 0.26% |
| 2017 FY | 378 Thousand USD | 10.85% |
| 2017 Q3 | 369 Thousand USD | 10.48% |
| 2017 Q2 | 334 Thousand USD | 2.14% |
| 2017 Q1 | 327 Thousand USD | -4.11% |
| 2017 Q4 | 378 Thousand USD | 2.44% |
| 2016 FY | 341 Thousand USD | 43.88% |
| 2016 Q3 | 277 Thousand USD | 3.36% |
| 2016 Q1 | 187 Thousand USD | 0.0% |
| 2016 Q2 | 268 Thousand USD | 43.32% |
| 2016 Q4 | 341 Thousand USD | 23.1% |
| 2015 FY | 237 Thousand USD | 6.28% |
| 2015 Q1 | 229 Thousand USD | 2.69% |
| 2015 Q3 | 48 Thousand USD | -31.43% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q2 | 70 Thousand USD | -69.43% |
| 2014 Q4 | 223 Thousand USD | 1.83% |
| 2014 Q1 | 1.47 Million USD | -61.29% |
| 2014 Q2 | 213 Thousand USD | -85.53% |
| 2014 Q3 | 219 Thousand USD | 2.82% |
| 2014 FY | 223 Thousand USD | -94.14% |
| 2013 Q4 | 3.8 Million USD | -28.65% |
| 2013 FY | 3.8 Million USD | -63.18% |
| 2013 Q2 | 7.57 Million USD | -12.85% |
| 2013 Q1 | 8.69 Million USD | -15.85% |
| 2013 Q3 | 5.33 Million USD | -29.65% |
| 2012 Q4 | 10.33 Million USD | -4.16% |
| 2012 Q3 | 10.77 Million USD | 62.27% |
| 2012 Q2 | 6.64 Million USD | 89.07% |
| 2012 Q1 | 3.51 Million USD | 147.22% |
| 2012 FY | 10.33 Million USD | 626.95% |
| 2011 Q3 | 504 Thousand USD | -78.87% |
| 2011 FY | 1.42 Million USD | 149.78% |
| 2011 Q1 | 1.05 Million USD | -86.5% |
| 2011 Q4 | 1.42 Million USD | 181.94% |
| 2011 Q2 | 2.38 Million USD | 126.97% |
| 2010 Q2 | 2.3 Million USD | 833.97% |
| 2010 FY | 568.91 Thousand USD | 348.04% |
| 2010 Q4 | 7.78 Million USD | 1268.19% |
| 2010 Q3 | 568.91 Thousand USD | -75.28% |
| 2010 Q1 | 246.41 Thousand USD | 43.58% |
| 2009 Q4 | 171.62 Thousand USD | 35.16% |
| 2009 FY | 126.97 Thousand USD | 202.34% |
| 2009 Q1 | 2555.00 USD | -94.13% |
| 2009 Q2 | 14.65 Thousand USD | 473.54% |
| 2009 Q3 | 126.97 Thousand USD | 766.5% |
| 2008 FY | 41.99 Thousand USD | 292.87% |
| 2008 Q4 | 43.51 Thousand USD | 3.6% |
| 2008 Q1 | 11.28 Thousand USD | -28.51% |
| 2008 Q2 | 7126.00 USD | -36.85% |
| 2008 Q3 | 41.99 Thousand USD | 489.36% |
| 2007 Q3 | 10.69 Thousand USD | -1.46% |
| 2007 Q4 | 15.78 Thousand USD | 47.64% |
| 2007 Q2 | 10.84 Thousand USD | -6.92% |
| 2007 Q1 | 11.65 Thousand USD | -9.7% |
| 2007 FY | 10.69 Thousand USD | -30.4% |
| 2006 FY | 15.36 Thousand USD | 173.21% |
| 2006 Q4 | 12.9 Thousand USD | -15.97% |
| 2006 Q3 | 15.36 Thousand USD | 584.49% |
| 2006 Q2 | 2244.00 USD | -91.64% |
| 2006 Q1 | 26.85 Thousand USD | 388.18% |
| 2005 Q1 | - USD | -100.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | 5500.00 USD | -2.17% |
| 2005 Q3 | 5622.00 USD | 0.0% |
| 2005 FY | 5622.00 USD | -8.41% |
| 2004 FY | 6138.00 USD | -11.65% |
| 2004 Q3 | 6138.00 USD | 141.27% |
| 2004 Q1 | 1902.00 USD | -85.32% |
| 2004 Q2 | 2544.00 USD | 33.75% |
| 2004 Q4 | 6827.00 USD | 11.23% |
| 2003 Q3 | 6947.00 USD | -73.98% |
| 2003 FY | 6947.00 USD | -64.52% |
| 2003 Q4 | 12.95 Thousand USD | 86.44% |
| 2003 Q2 | 26.69 Thousand USD | 18.21% |
| 2003 Q1 | 22.58 Thousand USD | 8.74% |
| 2002 FY | 19.58 Thousand USD | 12.42% |
| 2002 Q1 | 9609.00 USD | -63.0% |
| 2002 Q2 | 10.9 Thousand USD | 13.45% |
| 2002 Q4 | 20.77 Thousand USD | 6.07% |
| 2002 Q3 | 19.58 Thousand USD | 79.63% |
| 2001 Q4 | 25.96 Thousand USD | 49.08% |
| 2001 Q1 | 40.44 Thousand USD | -18.7% |
| 2001 Q2 | 40.84 Thousand USD | 1.01% |
| 2001 Q3 | 17.41 Thousand USD | -57.36% |
| 2001 FY | 17.41 Thousand USD | -54.66% |
| 2000 Q3 | 38.41 Thousand USD | 140.45% |
| 2000 Q4 | 49.74 Thousand USD | 29.48% |
| 2000 FY | 38.41 Thousand USD | 532.67% |
| 2000 Q2 | 15.97 Thousand USD | 0.0% |
| 1999 Q3 | 6072.00 USD | 0.0% |
| 1999 FY | 6072.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | 62.825% |
| Arem Pacific Corporation | 304.9 Thousand USD | -2912.676% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -4887.723% |
| BioCorRx Inc. | 10.34 Million USD | 11.175% |
| Bionik Laboratories Corp. | 5 Million USD | -83.615% |
| Banyan Corp. | 4.51 Million USD | -103.295% |
| Clearday, Inc. | 65.13 Million USD | 85.897% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -409.724% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -610645.868% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | 70.98% |
| Selectis Health, Inc. | 43.63 Million USD | 78.949% |
| Ethema Health Corporation | 17.71 Million USD | 48.16% |
| HealthLynked Corp. | 3.47 Million USD | -164.307% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | 36.54% |
| JRSIS Health Care Corporation | 2.3 Million USD | -298.483% |
| Comjoyful International Company | 6.32 Million USD | -45.204% |
| Medical Facilities Corporation | 235.37 Million USD | 96.097% |
| MedSmart Group Inc. | 927.53 Thousand USD | -890.343% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -880.492% |
| Nova Leap Health Corp. | 2.69 Million USD | -240.344% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -218.713% |
| PAO Group, Inc. | 1.04 Million USD | -777.706% |
| Primemd Inc. | 7.98 Million USD | -14.984% |
| Raffles Medical Group Ltd | 367.04 Million USD | 97.497% |
| Ryman Healthcare Limited | 5.17 Billion USD | 99.823% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -11307.314% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -134.58% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -116.251% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -1258.837% |
| Veltex Corporation | 2.87 Million USD | -219.255% |
| World Financial Holding Group | 132.5 Thousand USD | -6832.372% |
| Xcelerate Inc. | 2.07 Million USD | -342.565% |